Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

HYDERABAD, India (Reuters) - India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker Biocon Ltd said ahead of Prime Minister ...

Biocon aims to grow through new product launches in generics and biosimilars, bolstered by the Viatris acquisition. This ...

Biocon Ltd.'s disappointing Q3FY25 performance was largely due to exceptional items, with adjusted net profit standing at Rs 13 crore, and revenue growth of 7% on a like-for-like basis.

Biocon Ltd share price was up by 1.72% from the previous closing price of ₹390.25. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...

Shares of Biocon Ltd closed slightly higher at ₹357.15 on the BSE today, up 0.44% or ₹1.55, ahead of the earnings ...

Biocon Ltd is quoting at Rs 397.1, up 1.76% on the day as on 12:49 IST on the NSE. The stock is up 36.81% in last one year as compared to a 7.61% gain in NIFTY and a 18.78% gain in the Nifty Pharma ...

There is market share gain compared to last year. Any biosimilar might be able to take on a four-five or six player market, ...

The Competition Commission of India (CCI) recently imposed a penalty of ₹40 lakh on Goldman Sachs (India) Alternative Investment Manage ...